BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37533208)

  • 1. Clinical impact of hepatic steatosis on chronic hepatitis B patients in Asia: A systematic review and meta-analysis.
    Zhou R; Yang L; Zhang B; Gu Y; Kong T; Zhang W; Sun L; Liu C; Kong N; Li J; Shi J
    J Viral Hepat; 2023 Oct; 30(10):793-802. PubMed ID: 37533208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis.
    Wong YJ; Nguyen VH; Yang HI; Li J; Le MH; Wu WJ; Han NX; Fong KY; Chen E; Wong C; Rui F; Xu X; Xue Q; Hu XY; Leow WQ; Goh GB; Cheung R; Wong G; Wong VW; Yu MW; Nguyen MH
    Clin Mol Hepatol; 2023 Jul; 29(3):705-720. PubMed ID: 37157776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic steatosis: prevalence and host/viral risk factors in Iranian patients with chronic hepatitis B infection.
    Poortahmasebi V; Alavian SM; Keyvani H; Norouzi M; Mahmoodi M; Jazayeri SM
    Asian Pac J Cancer Prev; 2014; 15(9):3879-84. PubMed ID: 24935567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review with meta-analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B.
    Zheng Q; Zou B; Wu Y; Yeo Y; Wu H; Stave CD; Cheung RC; Nguyen MH
    Aliment Pharmacol Ther; 2021 Nov; 54(9):1100-1109. PubMed ID: 34469587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B.
    Huang SC; Su TH; Tseng TC; Chen CL; Hsu SJ; Liao SH; Hong CM; Liu CH; Lan TY; Yang HC; Liu CJ; Chen PJ; Kao JH
    Hepatol Int; 2023 Oct; 17(5):1139-1149. PubMed ID: 37247045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. East Asia expert opinion on treatment initiation for chronic hepatitis B.
    Kao JH; Hu TH; Jia J; Kurosaki M; Lim YS; Lin HC; Sinn DH; Tanaka Y; Wai-Sun Wong V; Yuen MF
    Aliment Pharmacol Ther; 2020 Nov; 52(10):1540-1550. PubMed ID: 32951256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrence and impact of hepatic steatosis on chronic hepatitis B patients: a systematic review and meta-analysis.
    Jiang D; Chen C; Liu X; Huang C; Yan D; Zhang X; Zhou Y; Lin Y; Zhou Y; Guan Z; Ding C; Lan L; Zhu C; Wu J; Li L; Yang S
    Ann Transl Med; 2021 Dec; 9(23):1718. PubMed ID: 35071412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy.
    Jiang XY; Huang B; Huang DP; Wei CS; Zhong WC; Peng DT; Huang FR; Tong GD
    World J Gastroenterol; 2021 Mar; 27(11):1101-1116. PubMed ID: 33776376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B.
    Lee J; Yoo SH; Sohn W; Kim HW; Choi YS; Won JH; Heo JY; Park SJ; Park YM
    Clin Mol Hepatol; 2016 Sep; 22(3):339-349. PubMed ID: 27729627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of non-invasive tests to assess advanced fibrosis in Asian subjects with chronic hepatitis B and concomitant hepatic steatosis.
    Lin KW; Kumar R; Shen F; Chan HL; Wong GL; Kumar R; Chow WC; Lin S; Wong VW; Fan JG; Goh GB
    Liver Int; 2023 May; 43(5):1008-1014. PubMed ID: 36855842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.
    Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
    Liver Int; 2009 Jul; 29(6):878-83. PubMed ID: 19192167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].
    Mi YQ; Liu YG; Xu L; Fan JG; Zhang H; Ping L; Shi RF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):817-20. PubMed ID: 19958639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there an influence of hepatic steatosis on fibrosis and necroinflammation in young patients with chronic viral hepatitis B?
    Karacaer Z; Okur G; Cermik H; Altun D
    Postgrad Med; 2016 Sep; 128(7):697-700. PubMed ID: 27499150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B.
    Seto WK; Hui RWH; Mak LY; Fung J; Cheung KS; Liu KSH; Wong DK; Lai CL; Yuen MF
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):575-583.e2. PubMed ID: 28970146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta-analysis.
    Mao X; Cheung KS; Peng C; Mak LY; Cheng HM; Fung J; Peleg N; Leung HH; Kumar R; Lee JH; Shlomai A; Yuen MF; Seto WK
    Hepatology; 2023 May; 77(5):1735-1745. PubMed ID: 36111362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia.
    Yang M; Wei L
    Liver Int; 2022 Aug; 42(9):1981-1990. PubMed ID: 35373500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC.
    Lee MH; Chen YT; Huang YH; Lu SN; Yang TH; Huang JF; Yin SC; Yeh ML; Huang CF; Dai CY; Chuang WL; Yu ML; Yang HI; Chen HY; Chen CJ
    Clin Gastroenterol Hepatol; 2024 Jun; 22(6):1275-1285.e2. PubMed ID: 38365094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B.
    Jin X; Chen YP; Yang YD; Li YM; Zheng L; Xu CQ
    PLoS One; 2012; 7(3):e34198. PubMed ID: 22479562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and virological characteristics of chronic hepatitis B patients with hepatic steatosis.
    Zheng RD; Chen JN; Zhuang QY; Lu YH; Chen J; Chen BF
    Int J Med Sci; 2013; 10(5):641-6. PubMed ID: 23569427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B.
    Li J; Yang HI; Yeh ML; Le MH; Le AK; Yeo YH; Dai CY; Barnett S; Zhang JQ; Huang JF; Trinh HN; Wong C; Wong C; Hoang JK; Cheung R; Yu ML; Nguyen MH
    J Infect Dis; 2021 Jul; 224(2):294-302. PubMed ID: 33249474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.